Spyre Therapeutics

About:

Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.

Twitter/X: spyretx

Top Investors: Cormorant Asset Management, Perceptive Advisors, RTW Investments, Woodline Partners, Deep Track Capital

Description:

Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies with the potential to revolutionize the treatment of inflammatory bowel disease (IBD).

Total Funding Amount:

$560M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2013-01-01

Founders:

Number of Employees:

51-100

Last Funding Date:

2024-11-18

IPO Status:

Public

Industries:

Biotechnology

Therapeutics